UCB Wins Two Key US Approvals: Bimzelx In Psoriasis, Zilbrysq In gMG

Launches To Follow In A Month, Late 2023

 
• By Mandy Jackson
  
Night speedy motion blur international race track with starting finishing line and confetti
Bimzelx crossed the US finish line after a lengthy delay • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip